Even if you dont feel thirsty, its extremely important to prioritize hydration when on these medications
In a 68-week clinical trial, participants on Wegovy (semaglutide) lost an average of 14.9% body weight compared to 2.4% in the placebo group
PubMed laboratory research record [PMID: 36037545] PubMed record related to this compound for laboratory literature review
How long does it take to get approved
Secondary outcomes The secondary outcomes are as follows: type 2 diabetes, glucose, HbA1c, insulin, lipid profile (LDL-cholesterol, HDL-cholesterol, triglycerides and apolipoprotein B), systolic blood pressure, diastolic blood pressure, and body mass index (BMI), which are well-established risk factors for CVD in clinical practice, or recently identified to be related to CVD in MR, such as apolipoprotein B [30, 31]
B.WoykeS.StrapazzonG.et al (2021)